A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease

2015135 citationsJournal Articlehybrid Open Access

Authors

Tomoyoshi Kondo · National Hospital Organization Hanamaki Hospital

Abstract

This study showed that istradefylline treatment was well tolerated and produced a sustained reduction in off time in levodopa-treated PD patients over a 52-week period.

Topics & Keywords

Adenosine and Purinergic Signaling Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Neuropharmacology

Volume 38, Issue 2, pp. 41-46

DOI: 10.1097/wnf.0000000000000073

Field-Weighted Citation Impact: 13.52